Option Care Health

Option Care Health

OPCH· Services· Fiscal year ends in December

CEO pay in FY2025Stock +37.3% in FY2025

John C. Rademacher is the CEO of Option Care Health and was paid $9.3M in FY2025 (Dec).

Pay$100 in the stock at the end of FY20 → $264
CEO pay is from each Option Care Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1John C. RademacherFY2025
  2. 2Luke WhitworthFY2025
  3. 3Michael ShapiroFY2025
  4. 4Collin G. SmyserFY2025
  5. 5Christopher L. GrashoffFY2025
  6. 6Meenal A. SethnaFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Option Care Health paid its 6 named executives $22.4M in total in FY2025 (Dec). CEO John C. Rademacher was paid $9.3M of that.

Name
John C. RademacherPresident and Chief Executive OfficerNot disclosedNot disclosed
Luke WhitworthChief Operating OfficerNot disclosedNot disclosed
Michael ShapiroFormer Chief Financial OfficerNot disclosed
Collin G. SmyserGeneral Counsel and Corporate SecretaryNot disclosed
Christopher L. GrashoffChief Growth OfficerNot disclosedNot disclosed
Meenal A. SethnaChief Financial OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers17

See all

The FY2025 (Dec) proxy of Option Care Health names 17 peer companies for pay. Among Option Care Health and these peers, CEO pay was the lowest of 6 and total shareholder return was 2nd highest of 6.

6th highest of 6in Option Care Health and its pay peers, FY2025 (Dec) by CEO pay:

$9.3M$18.3M

2nd highest of 6in Option Care Health and its pay peers, FY2025 (Dec) by total shareholder return:

$97$241

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

Filings6

See all
Proxy statementDEF 14AApr 8, 2026FY2025
Annual report10-KFeb 24, 2026FY2025
Proxy statementDEF 14AApr 2, 2025FY2024
Annual report10-KFeb 26, 2025FY2024
Proxy statementDEF 14AApr 3, 2024FY2023
Annual report10-KFeb 22, 2024FY2023